Leilei Zhou
About
In The Last Decade
Leilei Zhou
47 papers receiving 1.1k citations
Peers
Comparison fields: 5 of 117
- Molecular Biology 656
- Cancer Research 484
- Pulmonary and Respiratory Medicine 184
- Radiology, Nuclear Medicine and Imaging 166
- Oncology 116
Countries citing papers authored by Leilei Zhou
This map shows the geographic impact of Leilei Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leilei Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leilei Zhou more than expected).
Fields of papers citing papers by Leilei Zhou
This network shows the impact of papers produced by Leilei Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leilei Zhou. The network helps show where Leilei Zhou may publish in the future.
Co-authorship network of co-authors of Leilei Zhou
This figure shows the co-authorship network connecting the top 25 collaborators of Leilei Zhou. A scholar is included among the top collaborators of Leilei Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Leilei Zhou. Leilei Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 1 | |
| 3 | 4 | |
| 4 | 4 | |
| 5 | 2 | |
| 6 | 15 | |
| 7 | 6 | |
| 8 | 21 | |
| 9 | 5 | |
| 10 | 18 | |
| 11 | 29 | |
| 12 | 16 | |
| 13 | 20 | |
| 14 | 116 | |
| 15 | 10 | |
| 16 | 31 | |
| 17 | 41 | |
| 18 | 66 | |
| 19 | Gene cloning and prokaryotic expression of porcine haptoglobin and preparation of monoclonal antibodies | 0 |
| 20 | 19 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.